Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

By granting creators and inventors exclusive rights to their work, IP laws provide a powerful incentive for individuals and ...

By embracing a mix of co-innovation and best practices, stakeholders can boost productivity, streamline clinical trials, and ...

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

It is now possible to obtain three-dimensional, high-resolution images of enzyme activity in tissue samples or whole ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However ... uses machine learning to speed up the development time. The Waterloo research team has created ...

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.